cancer vaccine

News

IO Bio plans cancer vaccine filing despite trial miss

IO Biotech's cancer vaccine Cylembio failed to hit the mark in a phase 3 melanoma trial – but the company hopes to file for approval regardless.

Oncology

Redefining the future of melanoma treatment: Scancell's bold...

News

mRNA ‘wake-up call’ shows promise as universal cancer vaccin...

Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint inhibitor immunotherapy, significantly boosted anti-tumour activit

Oncology

Partner Content

Personalized Cancer Vaccine Summit

The Personalised Cancer Vaccine Summit will return to Boston this December!

Market Access

Deepening perspectives: How social media is driving our unde...

On the 31st of May, news broke that the NHS was launching its “world-first” cancer vaccine matchmaking programme.

News

ASCO: Moderna may file melanoma vaccine on phase 2b data

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme

IO Bio plans cancer vaccine filing despite trial miss

Redefining the future of melanoma treatment: Scancell's bold...

mRNA ‘wake-up call’ shows promise as universal cancer vaccin...

Personalized Cancer Vaccine Summit

Deepening perspectives: How social media is driving our unde...

ASCO: Moderna may file melanoma vaccine on phase 2b data

Veraxa says delayed US listing is back on track

How to meet your physicians where they are online

cancer vaccine

Editor's Picks